Imvanex Evropska unija - slovenščina - EMA (European Medicines Agency)

imvanex

bavarian nordic a/s - modificirani vakciniji virusa ankara - bavarska nordijska bolezen (mva-bn) - smallpox vaccine; monkeypox virus - druga virusna cepiva, - active immunisation against smallpox, monkeypox and disease caused by vaccinia virus in adults (see sections 4. 4 in 5. uporaba tega cepiva mora biti v skladu z uradnimi priporočili.

Mvabea Evropska unija - slovenščina - EMA (European Medicines Agency)

mvabea

janssen-cilag international n.v.    - recombinant modified vaccinia ankara bavarian nordic virus encoding the: ebola virus zaire (zebov) mayinga strain glycoprotein (gp); ebola virus sudan gulu strain gp; ebola virus taï forest strain nucleoprotein and the marburg virus musoke strain gp - hemoragične mrzlice, ebola - cepiva - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.

NOVANTRONE 2 mg/ml koncentrat za raztopino za injiciranje/infundiranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

novantrone 2 mg/ml koncentrat za raztopino za injiciranje/infundiranje

meda pharma gmbh & co. kg - mitoksantron - koncentrat za raztopino za injiciranje/infundiranje - mitoksantron 20 mg / 1 ml - mitoksantron

Tecovirimat SIGA Evropska unija - slovenščina - EMA (European Medicines Agency)

tecovirimat siga

siga technologies netherlands b.v. - tecovirimat - poxviridae infections; cowpox; monkeypox; vaccinia; smallpox - antivirusi za sistemsko uporabo - tecovirimat siga is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg:- smallpox- monkeypox- cowpoxtecovirimat siga is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4. 4 in 5. tecovirimat siga should be used in accordance with official recommendations.

BELOSALIC 0,5 mg / 20 mg v 1 g dermalna raztopina Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

belosalic 0,5 mg / 20 mg v 1 g dermalna raztopina

belupo, d.o.o., ljubljana - betametazon; salicilna kislina - dermalna raztopina - betametazon 0,5 mg / 1 g  salicilna kislina20 mg / 1 g; salicilna kislina 20 mg / 1 g - betametazon

BELOSALIC 0,5 mg / 20 mg v 1 g dermalna raztopina Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

belosalic 0,5 mg / 20 mg v 1 g dermalna raztopina

belupo, d.o.o., ljubljana - betametazon; salicilna kislina - dermalna raztopina - betametazon 0,5 mg / 1 g  salicilna kislina20 mg / 1 g; salicilna kislina 20 mg / 1 g - betametazon

BELOSALIC 0,5 mg / 30 mg v 1 g mazilo Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

belosalic 0,5 mg / 30 mg v 1 g mazilo

belupo, d.o.o., ljubljana - betametazon; salicilna kislina - mazilo - betametazon 0,5 mg / 1 g  salicilna kislina30 mg / 1 g; salicilna kislina 30 mg / 1 g - betametazon

Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics Evropska unija - slovenščina - EMA (European Medicines Agency)

prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics

novartis vaccines and diagnostics s.r.l. - površinski antigeni virusa influence (hemaglutinin in nevraminidaza) seva a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - cepiva - aktivna imunizacija proti podtipu h5n1 virusa influenca a. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

COVID-19 Vaccine (inactivated, adjuvanted) Valneva Evropska unija - slovenščina - EMA (European Medicines Agency)

covid-19 vaccine (inactivated, adjuvanted) valneva

valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - cepiva - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age.  the use of this vaccine should be in accordance with official recommendations.

Zoonotic Influenza Vaccine Seqirus Evropska unija - slovenščina - EMA (European Medicines Agency)

zoonotic influenza vaccine seqirus

seqirus s.r.l.  - zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted), influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/turkey/turkey/1/05 (h5n1)-like strain (nibrg-23) - influenza a virus, h5n1 subtype - cepiva - active immunisation against h5 subtype of influenza a virus.